Kevin Dinnell,Andrew P Lightfoot,Howard Robert Marshall
申请号：
US12936431
公开号：
US08377941B2
申请日:
2009.04.16
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The present invention relates to modulation of the α7 nicotinic acetylcholine receptor (nAChR) by a compound of List A or a salt thereof, which may be represented, but is not limited to the compound N-[(2-Trifluoromethyl-1H-indol-5-yl)methyl]-2-(trifluoromethyl)-5-pyrimidinecarboxamide.
